Description: Recombinant, Influenza Hemagglutinin Full-Length Glycoprotein (rHA GP) from virus strain A/Anhui/1/2013 (H7N9). Recombinant HA is supplied as an affinity purified protein. rHA is produced in Sf9 insect cells using baculovirus for expression and is purified by FPLC. Size: 50 µg of protein is supplied at a concentration of 0.293 mg/mL in Tris buffered saline plus 0.01% nonionic detergent. The theoretical molecular weight of the protein is ~62 kDa, without glycosylation. Because of the highly glycosylated nature of this protein, migration in an SDS-PAGE gel is slowed resulting in broad, diffuse bands representing differing glycosylation forms. Relevance: Recombinant hemagglutinin glycoprotein provides a control protein for immunoassays and a tool to enhance Orthomyxovirus research. Western Blot: Quality control testing demonstrates strong detection of GP null under reduced conditions when using anti-H7N9 rabbit monoclonal antibody. Storage: 2-3 weeks at -20°C, -80°C long term Intended for research use only, not for human, therapeutic, or diagnostic applications.
- UPC:
- 41122409
- Condition:
- New
- Availability:
- 3 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 1502-001
